Regeneron Pharmaceuticals (REGN)

$1,072.94 9.34 (0.88%)

13:12 EDT REGN Stock Quote Delayed 30 Minutes

Rating on Regeneron Pharmaceuticals (REGN) Upgraded to Buy From a Hold

By Portfolio Grader Oct 9, 2017

The current recommendation of Buy for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is computed using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. REGN has been upgraded from a Hold to a Buy in the last week.

4 Biotech Stocks (and 1 ETF) to Buy As They Bolt Higher

3 High-Risk, High-Reward Naked Puts

5 Biotech Stocks That Are Breaking Higher

Volume:

Previous Close -

Market Cap 98.47B

PE Ratio 31.69

EPS 33.86

Volume (Avg. Vol.) 97,377

Day's Range $1,064.95 - $1,078.71

52-Week Range $721.51 - $1,106.16

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

3 Large-Cap Biotech Stocks to Scrape From the Selloff

By Chris Tyler, InvestorPlace Contributor Aug 21, 2017

Large-cap biotech stocks like Regeneron, Celgene and Amgen are offering value both on and off the price chart. Here's how to profit.

3 Large-Cap Biotech Stocks to Buy Now

By Chris Tyler, InvestorPlace Contributor Jul 24, 2017

After a large correction, large-cap biotech stocks are positioned to enjoy their own bull market. We like these 3 stocks for bullish trades.

7 Stocks to Buy That Wall Street Analysts Hate

By Johnson Research Group Jul 20, 2017

Analysts hate to be wrong for too long, and their catch-up upgrades will send this list of stocks to buy to even more market-shattering gains.

3 Big Stock Charts for Thursday: Tripadvisor Inc (TRIP), Regeneron Pharmaceuticals Inc (REGN) and Lam Research Corporation (LRCX)

By Johnson Research Group Jul 20, 2017

Tripadvisor (TRIP), Lam Research (LRCX) and Regeneron REGN) all made one-day moves that confirmed that higher prices are likely over the next 2-3 months.

5 Biotech Stocks That Are Roaring Back to Life

By Anthony Mirhaydari, InvestorPlace Market Strategist Jun 21, 2017

These biotech stocks are making their way past recent lows based on a potential pause in focus and action by Trump.

Regeneron Pharmaceuticals Inc (REGN) Stock Looks Good Despite the Backdrop

By James Brumley, InvestorPlace Feature Writer Jun 20, 2017

Piper Jaffrey analyst Ed Tenthoff called REGN stock a buy today, seeing the bigger Regeneron Pharmaceuticals story that's about to unfold.

3 Biotech Trades to Diversify Your Portfolio

By Chris Tyler, InvestorPlace Contributor Jun 16, 2017

There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks.

5 Stocks with Solid Sales Growth Catching Eyeballs (REGN, RJF, DG, XEL, MS)

By Jun 14, 2017

Sales growth is an important indicator of a company's health and ability to sustain its business and these 5 stocks to buy are great examples

The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch

By Tyler Craig, Tales of a Technician Jun 14, 2017

Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop.

The 10 Highest-Paid CEOs for 2016

By William White, InvestorPlace Writer May 25, 2017

A study has been released that details the highest-paid CEOs in the U.S. for 2016 and Charter Communications' Tom Rutledge tops the list.

7 Stocks to Buy Now for BIG Summer Outperformance

By Johnson Research Group May 9, 2017

Don't slip into "sell in May and go away" nonsense. That's a rookie mistake. These 7 stocks to buy now will deliver in May, June and beyond.

4 Biotech Stocks That Could Be Rocked and Rolled This Month

By James Brumley, InvestorPlace Feature Writer May 4, 2017

If you own any of these biotech stocks (or are thinking about it), mark these four dates on your calendar. Things are going to get real interesting, real fast.

Go Long Regeneron Pharmaceuticals Inc (REGN) Stock at a Discount

By Nicolas Chahine, InvestorPlace Contributor May 4, 2017

Regeneron is up, and it's probably not wise to chase REGN stock right now, but there are safer ways to play it.

Is Now the Time to Buy Into These 5 Biotech ETFs?

By Mar 14, 2017

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

7 High-Risk, High-Reward Stocks to Buy Now

By Lawrence Meyers, InvestorPlace Contributor Feb 8, 2017

High-risk investments can be the difference between performance and outperformance. Here are 7 high-risk stocks to buy now for that part of your portfolio.